Menu

Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR Transcript
📰

Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR Transcript

All Articles on Seeking Alpha·16 days ago
#NY2hAQZC
#seekingalpha#research#results#today#trial
Reading 0:00
15s threshold

Edwards Lifesciences Corporation ( EW ) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR November 2, 2026 8:00 PM EST

Company Participants

Bernard Zovighian - CEO & Director

Daniel Lippis - Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific)

Conference Call Participants

Charles J Davidson

Michael Polark - Wolfe Research, LLC

Pito Chickering - Deutsche Bank AG, Research Division

Patrick Wood

David Rescott - Robert W. Baird & Co. Incorporated, Research Division

Philippe Genereux

Larry Biegelsen - Wells Fargo Securities, LLC, Research Division

Martin Leon

Robert Marcus - JPMorgan Chase & Co, Research Division

Travis Steed - BofA Securities, Research Division

Matthew Taylor - Jefferies LLC, Research Division

Joanne Wuensch - Citigroup Inc., Research Division

Conversation

Unknown Executive

All right. Glad everyone could join us today. Thanks so much for coming.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.